Literature DB >> 22080249

The phenomenology of autistic regression: subtypes and associated factors.

Ozalp Ekinci1, Ayse Rodopman Arman, Ismet Melek, Yasin Bez, Meral Berkem.   

Abstract

This study aimed to investigate the association of autistic regression (AR) and subtypes of AR with medical, developmental and psychiatric factors. Fifty-seven children with autistic spectrum disorders (ASD) were included in the study. Two types of AR are defined as regression after a normal social/language development (type 1) and regression as the worsening of previously reported autistic features (type 2). The frequency of history of AR was 56.1%. Male gender and sleep problems were found to be associated with a positive history of AR. The frequency of gastrointestinal complaints/diseases was higher in children with regression type 2 when compared to the children with regression type 1. Future studies with larger sample size and prospective design will contribute to clarifying the phenomenology and the associated factors of AR.

Entities:  

Mesh:

Year:  2011        PMID: 22080249     DOI: 10.1007/s00787-011-0228-7

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  32 in total

1.  Sleep problems in autism: prevalence, cause, and intervention.

Authors:  A L Richdale
Journal:  Dev Med Child Neurol       Date:  1999-01       Impact factor: 5.449

2.  Developmental regression in autism: maternal perception.

Authors:  M Davidovitch; L Glick; G Holtzman; E Tirosh; M P Safir
Journal:  J Autism Dev Disord       Date:  2000-04

3.  Characterizing sleep in children with autism spectrum disorders: a multidimensional approach.

Authors:  Beth A Malow; Mary L Marzec; Susan G McGrew; Lily Wang; Lynnette M Henderson; Wendy L Stone
Journal:  Sleep       Date:  2006-12       Impact factor: 5.849

4.  Infantile autism with speech loss before the age of thirty months.

Authors:  H Kurita
Journal:  J Am Acad Child Psychiatry       Date:  1985-03

5.  Behavior checklist for identifying severely handicapped individuals with high levels of autistic behavior.

Authors:  D A Krug; J Arick; P Almond
Journal:  J Child Psychol Psychiatry       Date:  1980-07       Impact factor: 8.982

6.  Regression versus no regression in the autistic disorder: developmental trajectories.

Authors:  P Bernabei; A Cerquiglini; F Cortesi; C D'Ardia
Journal:  J Autism Dev Disord       Date:  2007-03

Review 7.  Sleep in children with autistic spectrum disorder.

Authors:  Flavia Cortesi; Flavia Giannotti; Anna Ivanenko; Kyle Johnson
Journal:  Sleep Med       Date:  2010-07-04       Impact factor: 3.492

8.  Autistic and dysphasic children. I: Clinical characteristics.

Authors:  R F Tuchman; I Rapin; S Shinnar
Journal:  Pediatrics       Date:  1991-12       Impact factor: 7.124

9.  Developmental regression in children with an autism spectrum disorder identified by a population-based surveillance system.

Authors:  Lisa D Wiggins; Catherine E Rice; Jon Baio
Journal:  Autism       Date:  2009-07

10.  Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS).

Authors:  E Schopler; R J Reichler; R F DeVellis; K Daly
Journal:  J Autism Dev Disord       Date:  1980-03
View more
  4 in total

1.  Characteristics, Early Development and Outcome of Parent-Reported Regression in Autism Spectrum Disorder.

Authors:  Sofie Boterberg; Rudy Van Coster; Herbert Roeyers
Journal:  J Autism Dev Disord       Date:  2019-11

2.  From "ready to wear" to "custom-made": the benefits of multidimensional approaches to tailor targeted interventions.

Authors:  Catherine Barthélémy
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-01       Impact factor: 4.785

3.  A Review of the Differences in Developmental, Psychiatric, and Medical Endophenotypes Between Males and Females with Autism Spectrum Disorder.

Authors:  Eric Rubenstein; Lisa D Wiggins; Li-Ching Lee
Journal:  J Dev Phys Disabil       Date:  2015-02

4.  Is Autism Inborn And Lifelong For Everyone?

Authors:  Paul Whiteley; Kevin Carr; Paul Shattock
Journal:  Neuropsychiatr Dis Treat       Date:  2019-10-07       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.